| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0924-8579(99)00149-1 |
| P698 | PubMed publication ID | 10717503 |
| P2093 | author name string | Farthing MJ | |
| P2860 | cites work | Escherichia coliO157:H7 and the Hemolytic–Uremic Syndrome | Q33488736 |
| Recent treatment with H2 antagonists and antibiotics and gastric surgery as risk factors for Salmonella infection | Q34321989 | ||
| Omeprazole as a risk factor for campylobacter gastroenteritis: case-control study | Q34375221 | ||
| History and rationale of oral rehydration and recent developments in formulating an optimal solution. | Q39567196 | ||
| Enhancing clinical efficacy of oral rehydration therapy: is low osmolality the key? | Q40872992 | ||
| Recently recognised microbial enteropathies and HIV infection | Q41119690 | ||
| The enkephalinase inhibitor, acetorphan, in acute diarrhoea. A double-blind, controlled clinical trial versus loperamide | Q70702476 | ||
| Effect of granisetron on cholera toxin-induced enteric secretion | Q73321142 | ||
| P433 | issue | 1 | |
| P921 | main subject | diarrhea | Q40878 |
| P304 | page(s) | 65-69 | |
| P577 | publication date | 2000-02-01 | |
| P1433 | published in | International Journal of Antimicrobial Agents | Q15724616 |
| P1476 | title | Diarrhoea: a significant worldwide problem | |
| P478 | volume | 14 |
| Q28070368 | A Comprehensive Comparison of the Efficacy and Tolerability of Racecadotril with Other Treatments of Acute Diarrhea in Adults |
| Q40442464 | A common, symptom-based case definition for gastroenteritis |
| Q38015827 | A comprehensive review of the pharmacodynamics, pharmacokinetics, and clinical effects of the neutral endopeptidase inhibitor racecadotril |
| Q40222268 | Aetiologies of diarrhoea in adults from urban and rural treatment facilities in Bangladesh |
| Q36724430 | Ageing and the gut |
| Q37821500 | Beneficial effects of lactic acid bacteria on human beings. |
| Q44572244 | Characterization of diarrhoeagenic Escherichia coli isolates in Jordanian children |
| Q35444891 | Childhood diarrhoea: failing conventional measures, what next? |
| Q36101210 | Considerations for development of whole cell bacterial vaccines to prevent diarrheal diseases in children in developing countries |
| Q37088080 | Contaminated water delivery as a simple and effective method of experimental Salmonella infection |
| Q89135149 | Development of an Electrochemical DNA Biosensor to Detect a Foodborne Pathogen |
| Q50099844 | Diarrhoea in elderly people: aetiology, and clinical characteristics |
| Q34740218 | Dissemination of persistent intestinal bacteria via the mesenteric lymph nodes causes typhoid relapse. |
| Q45986666 | Electrophysiological characterization of chloride secretion across the jejunum and colon of pigs as affected by age and weaning. |
| Q79806616 | Estimating the burden and cost of infectious intestinal disease in the Maltese community |
| Q35685963 | Ethnomedicinal plants used for diarrhea by tribals of Meghalaya, Northeast India |
| Q37233997 | Gastroenterology in developing countries: issues and advances |
| Q34634491 | Generation of Salmonella-specific Th1 cells requires sustained antigen stimulation |
| Q56686468 | Herbal medicine acceptance, sources and utilization for diarrhoea management in a cosmopolitan urban area (Thika, Kenya) |
| Q89896260 | In Silico, Ex Vivo and In Vivo Studies of Roflumilast as a Potential Antidiarrheal and Antispasmodic agent: Inhibition of the PDE-4 Enzyme and Voltage-gated Ca++ ion Channels |
| Q93486487 | Le traitement de la diarrhée |
| Q26766632 | Management of children with prolonged diarrhea |
| Q34304499 | Microbes and microbial toxins: paradigms for microbial-mucosal interactions. VIII. Pathological consequences of rotavirus infection and its enterotoxin |
| Q34421758 | Nutritional aspects of nitric oxide: human health implications and therapeutic opportunities |
| Q37167063 | Pathogenic microorganisms associated with childhood diarrhea in low-and-middle income countries: case study of Yaoundé - Cameroon |
| Q30436681 | Pathophysiology and impact of enteric bacterial and protozoal infections: new approaches to therapy |
| Q35087885 | Racecadotril versus loperamide: antidiarrheal research revisited |
| Q42472620 | Recurrent networks of submucous neurons controlling intestinal secretion: a modeling study. |
| Q34119319 | Rhubarb tannins extract inhibits the expression of aquaporins 2 and 3 in magnesium sulphate-induced diarrhoea model. |
| Q36271347 | Safety assessment and risk-benefit analysis of the use of azodicarbonamide in baby food jar closure technology: putting trace levels of semicarbazide exposure into perspective--a review |
| Q30360953 | Shiga toxin 2a and Enteroaggregative Escherichia coli--a deadly combination |
| Q57111021 | The Anti-diarrheal Activity of the Non-toxic Dihuang Powder in Mice |
| Q79561191 | The magnitude and distribution of infectious intestinal disease in Malta: a population-based study |
| Q33398124 | The role of lymphostatin/EHEC factor for adherence-1 in the pathogenesis of gram negative infection |
| Q82284780 | Treatment of diarrheal disease |
| Q30857527 | Utilizing Healthcare Developments, Demographic Data with Statistical Techniques to Estimate the Diarrhoea Prevalence in India |
Search more.